First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
Condition: Phenylketonuria Interventions: Drug: JNT-517 Suspension; Drug: Placebo Suspension; Drug: JNT-517 Tablet; Drug: Placebo Tablet Sponsor: Jnana Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials